Capital Research Global Investors
NVO

Capital Research Global Investors’s Novo Nordisk NVO Stock Holding History

Capital Research Global Investors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.98M Buy
103,059
+4,146
+4% +$178K ﹤0.01% 409
2026
Q1 		$3.49M Buy
98,913
+52,590
+114% +$2.49M ﹤0.01% 441
2025
Q4 		$2.37M Sell
46,323
-2,903
-6% -$148K ﹤0.01% 423
2025
Q3 		$2.73M Sell
49,226
-13,403
-21% -$785K ﹤0.01% 424
2025
Q2 		$4.29M Buy
62,629
+5,099
+9% +$347K ﹤0.01% 416
2025
Q1 		$3.99M Buy
57,530
+9,280
+19% +$766K ﹤0.01% 438
2024
Q4 		$4.14M Sell
48,250
-6,636
-12% -$718K ﹤0.01% 423
2024
Q3 		$6.63M Buy
54,886
+4,669
+9% +$623K ﹤0.01% 398
2024
Q2 		$7.26M Buy
50,217
+2,984
+6% +$395K ﹤0.01% 394
2024
Q1 		$6.06M Buy
47,233
+13,181
+39% +$1.57M ﹤0.01% 397
2023
Q4 		$3.52M Buy
34,052
+407
+1% +$40.2K ﹤0.01% 396
2023
Q3 		$3.08M Buy
33,645
+1,111
+3% +$97.9K ﹤0.01% 401
2023
Q2 		$2.55M Buy
32,534
+506
+2% +$41.3K ﹤0.01% 407
2023
Q1 		$2.53M Sell
32,028
-12,224
-28% -$867K ﹤0.01% 416
2022
Q4 		$2.99M Buy
+44,252
New +$2.59M ﹤0.01% 422
2018
Q3 		– Sell
-22
Closed -$1K – 460
2018
Q2 		$1K Sell
22
-2
-8% -$48 ﹤0.01% 433
2018
Q1 		$1K Buy
24
+14
+140% +$368 ﹤0.01% 435
2017
Q4 		$0 Hold
10
– – ﹤0.01% 439
2017
Q3 		$0 Buy
+10
New +$226 ﹤0.01% 438

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors's NVO Position: Q2 2026 in Review

Capital Research Global Investors increased its Novo Nordisk (NVO) stake by 4.2% in Q2 2026, buying an estimated $178K and bringing the position to 103,059 shares worth $4.98M. The position accounts for ﹤0.01% of the portfolio, ranked #409.

Capital Research Global Investors first reported a position in NVO in Q3 2017 and has held it in 19 quarters since. The position peaked at $7.26M in Q2 2024. 1,132 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Capital Research Global Investors held 103,059 shares of Novo Nordisk worth $4.98M as of Q2 2026.
  • Capital Research Global Investors bought 4,146 Novo Nordisk shares in Q2 2026, an estimated $178K.
  • Novo Nordisk made up ﹤0.01% of Capital Research Global Investors's portfolio in Q2 2026, its #409 holding.
  • Capital Research Global Investors first reported a position in Novo Nordisk in Q3 2017 and has held it in 19 quarters since.
  • Capital Research Global Investors's Novo Nordisk position peaked at $7.26M in Q2 2024.
  • 1,132 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Capital Research Global Investors's 13F filing for Q2 2026, filed 12 Aug 2026.